Yes. In our continuing focus on how the patients can become more involved and educated on their care both in clinical trials and and through their care, we focus today on the first crowd-sourcing protocol approved by the FDA for a clinical trial. Released Tuesday, Transparency LifeSciences, LLC
"lisinopril as an adjunctive therapy for multiple sclerosis (MS)".
In order to make clinical trial participation easier for the participants, telemonitoring and other methods will be used to collect data during the trial. The patients will only have to come into a site at the beginning and end of a trial. According to CrowdSourcing.com, To continue making the trial easier for all involved, they are crowdsourcing the collection process through Protocol Builder TM to collect insights from patients, physicians and researchers to continue to improve the innovative trial process through the clinical trial process.
At Partnerships in Clinical Trials 2013, Amy O’Connor, Director of Digital Government Affairs, Eli Lilly & Co. and Aaron Fleishman, Social Media Marketing, BBK Worldwide will be on hand to present Effective Social Media Use to Advance Clinical Trials. During this presentation, they will look at how Pharma can use tools such as these to keep up with the ever changing patient population, which can be found online and are willing to contribute their input into better treatment and care. For more information on this session and the rest of the program, download the agenda. If you'd like to join us in Orlando April 22-24, 2013, as a reader of this blog, when you register to join us and mention code XP1800BLOG, save 15% off the standard rate!
Does Pharma have to continue to evolve clinical trials such as these to keep up with their participants? Do you see something like this improving the number of patients willing to participate?
Drug Development in Alzheimer’s Disease: Reasons to Remain Optimistic
Date: Thursday, September 18, 2014
Time: 10:00 AM - 11:00 AM EDT
Mention proirity code XP2000W1BLOG
The Partnerships in Clinical Trials Blog focuses optimization intelligence, regulatory trends and globalization strategies for both as sponsors and CROs. It is supported by a number of industry events:
Would you like to guest blog on our site? Or send us feedback? Send an email to firstname.lastname@example.org.